Study author comments on the results of the Lucentis, Eylea, Avastin in Vein Occlusion (LEAVO) trial
LEAVO study compares anti-VEGF agents in vein occlusion
LEARN MORELEAVO study compares anti-VEGF agents in vein occlusion
LEARN MOREAPOLLON interim results show good real-world outcomes of aflibercept in DME.
LEARN MORELiterature review compares aflibercept and ranimizumab in real-world settings.
LEARN MOREAntonio Capone Jr., MD, talks about the controversial use of anti-VEGFs in the treatment of ROP.
LEARN MOREError